Home › Cancro del polmone non a piccole cellule › Illinois › Evanston
Studi clinici su Cancro del polmone non a piccole cellule a Evanston, IL
22 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Evanston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- Illinois Cancer Specialists /ID# 274678, Niles · a 6 mi di distanza
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
In reclutamentoFase 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · a 2 mi di distanza
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · a 5 mi di distanza
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
- e altri 1
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
In reclutamentoFase 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
In reclutamentoFase 3
- North Shore University Health System ( Site 4014), Evanston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
In reclutamentoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi di distanza
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi di distanza
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
In reclutamentoFase 3
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
In reclutamentoFase 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
In reclutamentoFase 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · a 6 mi di distanza
- Advocate Medical Group Oncology, Park Ridge · a 8 mi di distanza
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
In reclutamentoStudio osservazionale
- Orchard Healthcare Research Inc., Skokie · a 2 mi di distanza
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Niles · a 6 mi di distanza
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
In reclutamentoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
In reclutamentoFase 2
- Advocate Aurora Health, Park Ridge · a 8 mi di distanza
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
GEMINI-NSCLC: NSCLC Biomarker Study
In reclutamentoStudio osservazionale
- Northwestern University, Evanston
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Evanston
- Cancro ai polmoni19 studi
- Cancro al seno13 studi
- Obesità12 studi
- Leucemia mieloide acuta11 studi
- Sovrappeso10 studi
- Cancro colorettale10 studi
- Cancro (tutti i tipi)9 studi
- Malattia di Crohn9 studi
- Colite ulcerosa9 studi
- Cancro alla prostata9 studi
- Melanoma8 studi
- Fibrillazione atriale8 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.